Auction Price, Injury Ledger: How the Fast Bowler's Value Got Re-Coded at the 2026 Franchise Auction

Auction Price, Injury Ledger: How the Fast Bowler's Value Got Re-Coded at the 2026 Franchise Auction

Sitting in the auction room last season, I noticed something that never appears on a scoreboard but always appears on the price sheet. A right-arm pacer — fourteen matches, twenty-four wickets, an economy of 8.4 at the death — went unsold at base price. Cutting right past him, another bowler whose entire record over the previous eight months amounted to six matches walked away with thirty million rupees. The two franchise analysts at the table were both people I know; both were reading from the same database. The price still split in two, and both of them called their own decision "rational."

Since that night I have been circling one question: does the auction actually buy performance, does it buy injury risk, or does it buy a third thing none of us names out loud?

I traced the pass back until the highlight forgot where it began. This time I traced a price. Because a price is a kind of highlight too — a two-minute clip in which nobody knows what that pacer's shoulder, elbow, and ankle were doing over the preceding four months.

We file football's transfer window and cricket's auction in the same drawer, but they are different animals. In football, a fee moves from club to club, an agent turns in the middle, and a medical table makes the final call. The cricket auction has no such mediation; it has a central stage, a base price, and a hand that rises and falls within two minutes. What football calls a medical review, cricket often calls a slip of paper reading "fitness cleared." That slip is now the data point I trust least.

The 2026 calendar sits at the centre of all this. Franchise leagues, international series squeezed between them, T20 World Cup preparation, domestic tournaments — together they place roughly one and a half times the annual delivery load on an international pacer compared with a decade ago. Across nineteen years of covering this game, I have seen that fixture congestion is itself the biggest injury-maker; no medical team can save a pacer from a two-games-a-week squeeze, it can only delay how late the damage shows up. The auction room knows this and refuses to admit it.

So over the past three months I re-coded a model. I called it Availability-Adjusted Value, or AAV. The aim is simple: when pricing a pacer at auction, place "availability" beside his wickets and economy — how many matches can he actually bowl in, and what sits behind that availability is workload, an age curve, and recurrence history.

I began with pacer data from several T20 leagues between 2026 and 2026. I split deliveries per four weeks, the share of those at the death, the share in the powerplay, then the difference in pace and accuracy across the first six weeks after returning from an injury break. The picture at the first layer was not comfortable.

Beyond a certain workload threshold, wicket efficiency stops rising and only injury probability rises. In my dataset, pacers who averaged more than roughly 420 deliveries per four weeks suffered injury breaks in the following two months at about 2.3 times the rate of those below 420. Yet at the auction table nobody asks for that 420. They ask for death-over economy and powerplay wickets. The market buys the variables visible in two minutes and avoids the variable that takes two months to form.

The second layer is more uncomfortable still. I divided injury history into three kinds: soft tissue (hamstring, groin), joint (elbow, ankle), and stress/back. The same injury returning within two seasons roughly doubled the chance of a third recurrence, and a third recurrence brought a far sharper performance decline — economy and strike rate combined — than the first. The market price, however, runs the other way: after a third injury the familiar name still does not lose value, because "the name" is a separate asset.

At the third layer I added something no scouting report contains: the tier of a franchise's medical infrastructure. This is where my model first went wrong, and that error sent me back to my readers.

Last February I shared a simplified version of my AAV on Twitter with a poll: "If you owned a franchise, would you buy an injury-prone match-winner or a fit but blunter option?" About nine thousand votes arrived in twenty-four hours. Fifty-six percent said "the match-winner, I'll take the risk." But the interesting part was the comments: many fans asked, "Which franchise? Whose physio?"

The model did not change because of the speed; it changed because you voted. That one question flipped my entire framework. I realised I had been treating injury risk as a fixed number, when risk is never fixed — it depends on who is managing it.

So I re-coded the model. This time I gave each franchise a "recovery tier," from tier one to tier four. The basis was continuity of physio staff, a prior record in injury management (how many pacers returned from injury with their pace intact), a history of workload rotation, and whether an equivalent bowler sat on the reserve bench.

The result was clear to me and hard to say publicly: the same pacer's AAV is about thirty-eight percent higher to a tier-one franchise than to a tier-four one. In other words, the price of an injury-prone bowler is not set by his own body; it is set by the system of whoever sits across the table. When I first saw that number I did not believe it. I separated and cross-checked three seasons of pacer rotation for each franchise, then accepted it.

An old habit helped me here. Early in my career I made a rule — put a "fan objections" section in every scouting report. That section was never for pleasing readers; it was my error-check. The same thing happened again. The people who raised the physio in the comments built my model's most valuable feature, one I had not seen myself.

Every number has a first touch, and every first touch has a witness. My AAV's first touch was an auction price, and its witnesses were those two thousand commenters, many of whom have never coded a ball in their lives.

Now the contrarian question, which matters most to me. When I say "the market misprices injury risk," I can easily fall into a trap — assuming the market is inefficient. But the market may not be inefficient; it may be pricing something I am not measuring.

Suppose the pacer who went unsold would have gone to a tier-four franchise with nobody to manage his workload. And suppose the pacer who fetched thirty million went to a tier-one side with a clear rotation system. Then the price looks absurd but is in fact rational — my model had simply been sitting in the wrong spreadsheet at first. I do not worship the dashboard; I ask who is missing from it. My first dashboard had no physio staff; that gap was the real story.

But there is a sharper possibility here, and I will not dodge it. Perhaps the auction does not buy injury, does not buy availability, and does not even buy performance. Perhaps it buys "the name" — that rare asset that brings sponsors, sells jerseys, and keeps a franchise in the conversation. Seen this way, thirty million for a six-match pacer is not sudden foolishness; it is marketing arithmetic sitting at the same table as cricket arithmetic. And here I stop, because to me numbers speak and names stay silent.

Still, one thing has lodged in me, and it will return most this season. In football transfers we say "follow the money." At a cricket auction I now say: follow the physio. Everyone sees the money; nobody sees the person standing behind the table who will decide whether your thirty-million pacer can bowl in October.

Why has nobody built this framework before? Because in our analysis availability is always a matter of shame, an excuse. We say "he's injury-prone," and the conversation ends. Yet availability is a pacer's most valuable metric, if you read it not as injury but as a predictive variable.

One thing must be clear. This AAV model is no final verdict. It is a version, v2.2, which I have written down publicly and re-coded on the basis of fan votes. Last month a reader wrote on my thread, "You measure workload, but you don't measure travel." He is right. Flights, time-zone shifts, biorhythm — I have not yet put these into the model, because the data is incomplete. Admitting that is a sign of strength for me, not weakness.

When I look at two decades of pacer history, a pattern is clear. In my covering life I have seen three generations of fast bowling. The first generation played 25–30 matches a year but broke down within five or six years. The second generation brought rotation, but unevenly — some franchises did it, others did not. The third generation, the one now underway, has turned medical staff itself into an investment. The best pacers of this third generation bowl less, play more, yet the price sheet still barely reflects the shift.

And here is my second observation, perhaps this season's most unwelcome truth. We all say fixture congestion is the calendar's fault, not the player's. But in the auction room that calendar risk lands entirely on the franchise's shoulders, and the franchise solves it by trimming a pacer — branding him injury-prone, buying him cheap, then parking him on the bench. Personally I think this is the quietest injustice done to a player, because the one who pays for the system he did not create is the very person carrying its heaviest load.

My Bangladeshi readers will find this familiar. For our pacers the arithmetic is even crueller. With international series, franchise leagues, and preparation all falling on bowlers like Mustafizur Rahman or Taskin Ahmed, a single small soft-tissue injury derails an entire team plan. We can produce talent, but we have not yet invested in the infrastructure to keep talent alive. This gap is not ours alone; it is a common problem of small cricket economies.

One thing I will stress, because it has returned again and again in three years of coverage: when the calendar turns greedy, the doctor never wins. However modern your sports science, the nerve, muscle, and bone of a pacer cannot recover on the same rhythm under a two-games-a-week squeeze. This is the truth inside my model, and it is the least discussed truth at the auction table.

Does all this mean franchises are stupid? No. It means they are evaluating a variable whose data they do not have, so they are guessing. And the biggest problem with guessing is that it usually looks back at last season's scoreboard, not forward at a body's future.

So this season, when hands rise in the auction room, I will watch two things at once. First, what the workload curve of the unsold pacer was showing over his last four months. Second, how many pacers the franchise that passed on him has returned to full pace from injury over the past three years. I will compare the two numbers, then reach a verdict — whether this price is cricket's arithmetic or shame's arithmetic.

I am leaving you a task too. Next time you see a pacer go unsold at base price, do not conclude from his injury record alone. Look at the table behind him, look at that franchise's rotation system, and ask: has this man's body really broken, or is this system pushing it toward breaking?

Because in the end, price and body are two sides of the same data. One shows up on the table, the other only next season. And my job is to stand between those two sides and hunt the truth — with a model that gets re-coded every time by your votes and your comments.

I do not worship the dashboard; I ask who is missing from it. This season, the one missing from the dashboard will be a physio whose name nobody remembers. And that name may well be your auction's most valuable purchase.